Physicians Off The Beaten Path - 43- Physician-Scientist Series: Leo Anthony Celi (MIT Laboratory of Computational Physiology)

43- Physician-Scientist Series: Leo Anthony Celi (MIT Laboratory of Computational Physiology)

05/25/23 • 50 min

What factors must we overcome for healthcare Machine Learning to reach its full potential? How can LMICs globally be included in the healthcare informatics and data ecosystem?
Join this episode as Dr. Leo Anthony Celi answers these questions and talks about the future of AI in health!

Leo is the Clinical Research Director and Principal Research Scientist at the Massachusetts Institute of Technology Laboratory of Computational Physiology and a Staff Physician at the Division of Pulmonary, Critical Care, and Sleep Medicine at Beth Israel Deaconess Medical Center. He holds an MPH in Clinical Effectiveness from Harvard University School of Public Health, an MSc in Biomedical Informatics from MIT, and an MD in Medicine from the University of the Philippines.

We volunteer our time and money to make this content freely available – if you enjoy our content and find it helpful, you can support us by buying us a coffee here!

Previous Episode

42- Physician-Entrepreneur Series: David Grew (PRIMR)

How does one identify the market opportunity and the go-to-market strategy? And how can one drive market adoption while being a practicing physician? What is the current state of medical education? And how can it improve to unleash the creative potential of doctors? David Grew addresses these questions and other topics on our 42nd episode.

David is the founder of PRIMR, an application that allows physicians to provide patients with digitally recorded, personalized explanations regarding their medical conditions and treatments.

David is a Connecticut-based radiation oncologist practicing at Trinity Health of New England. He holds an MD from Tulane University School of Medicine and an MPH from Tulane University School of Public Health and Tropical Medicine.

We volunteer our time and money to make this content freely available – if you enjoy our content and find it helpful, you can support us by buying us a coffee here!

Next Episode

44- Physician-Entrepreneur Series: Lincoln Nadauld (Culmination Bio, Clarified Precision Medicine & Guidance Genome)

Join us as Lincoln Nadauld, CEO of Culmination Bio, delves into the crucial role of genomics-powered precision medicine in Oncology research. Discover the main challenges hindering the adoption of precision medicine in clinical oncology. Gain insights on effectively managing your time between clinical medicine and the industry. Don't miss Lincoln's inspiring journey!

Lincoln Nadauld is the CEO of Culmination Bio, a biotech company leveraging unique data sets from diverse biosamples containing vast biological data enriched with clinical data.

He was VP and Chief of Precision Health and Academics at Intermountain Healthcare, where he led precision health across 24 hospitals and 200 clinics, overseeing Graduate Medical Education. He is the co-founder of Clarified Precision Medicine as well as Guidance Genome.

Lincoln graduated from Bountiful High School. He played rugby while getting his undergraduate degree at BYU, his Doctor of Medicine, and his Doctor of Philosophy from the University of Utah. Then he did his clinical training in oncology at Stanford University.

We volunteer our time and money to make this content freely available – if you enjoy our content and find it helpful, you can support us by buying us a coffee here!